INTRODUCTION

In Jurkat T cells, activation of the T-cell receptor (TCR)-CD3
complex results in recruitment of tyrosine kinases that are members of the src family including fyn and lck. It has been proposed that the src family of tyrosine kinases activate a phospholipase C isoform, γ1, which in turn stimulates phosphoinositide hydrolysis, leading to the generation of inositol 1,4,5-trisphosphate (IP $ ) [1] [2] [3] . IP $ triggers intracellular calcium release [4, 5] . Emptying of the intracellular calcium stores generates a Ca# + influx through a calcium release-activated channel (CRAC), possibly opened by a calcium influx factor (CIF) as described by Randriamampita and Tsien [6] . The first steps involved in T-cell activation are bypassed when using the endoplasmic reticulum Ca# + -ATPase blocker, thapsigargin [7, 8] . This compound passively decreases the Ca# + level in the endoplasmic reticulum, allowing the CRAC to open. The effects of La$ + on Ca# + signalling have been previously tested in lachrymal cells (in the range 30-500 µM) [9] , in salivary acinar cells at 1 mM [10] and in C6-2B glioma cells at 200 µM [11] . At these high concentrations, La$ + has been shown to inhibit membrane Ca# + -ATPase and Ca# + entry in cells treated with thapsigargin. We show here that in Jurkat T lymphocytes, submicromolar La$ + concentrations block capacitative Ca# + entry as well as Mn# + entry (when Mn# + was used as a surrogate for Ca# + ). Activation of T cells via the TCR can be monitored by measuring the expression of CD25 and CD69. CD25 is a 55 kDa protein that forms a low-affinity receptor for interleukin-2 (IL-2). CD25, when associated with the 75 kDa component of the IL-2 receptor, forms a heterodimer of high affinity for this interleukin. CD69, a disulphide-linked dimeric structure including a 33 kDa and a 27 kDa chain, is the earliest molecule that appears de no o on the lymphocyte surface on activation. We show here that blocking Ca# + entry induced by TRC activation results in a lack of surface expression of both CD25 and CD69. 
MATERIALS AND METHODS
Cells
The human T-cell line Jurkat was kindly supplied by Dr. 
Measurements of changes in cytosolic [Ca 2 + ]
The assay of cytosolic [Ca# + ] was performed by using Indo-1 (Calbiochem) [12] . Cells (5i10'\ml) were loaded by using 5 µM Indo-1 at 37 mC in the dark for 1 h and then washed and resuspended in Hepes buffered saline (140 mM NaCl, 5 mM KCl, 1 mM CaCl # , 1 mM MgCl # , 10 mM glucose, 20 mM Hepes, 0.1 % BSA, pH 7.4). When necessary, calcium was omitted. The analyses were performed on a fluorescence-activated cell sorter (FACStar Plus, Becton Dickinson) fitted with two argon lasers, one tuned to 488 nm (250 mV) to gate out debris and damaged cells according to the dual-scatter dot plot, and the other to UV (100 mV, 351-364 nm) to excite Indo-1 fluorescence. The fluorescence intensities at 480 and 400 nm, corresponding to the free Indo-1 and the complex Ca# + -Indo-1 concentrations respectively, were measured. Calculation of the ratio of fluorescence at 400 nm to that at 480 nm allows the evaluation of changes in cytosolic free Ca# + concentration ([Ca# + ] i ) independently of the cell size and the intracellular Indo-1 concentration. The flow rate was set to 1000 cells\s and the mean ratio of 3000 cells was noted every 30 s.
Measurement of Mn 2 + entry
Mn# + uptake was monitored by the quenching of the Indo-1 fluorescence at 430 nm, which is insensitive to variations in
Phosphatidylserine synthesis
Jurkat cells (2i10') were maintained in 0.5 ml of a buffer (pH 7.4) containing 137 mM NaCl, 2.7 mM KCl, 2.5 mM glucose, 20 mM Hepes, 1 mM MgCl # and 1 mM CaCl # at 37 mC in the presence of 4 µCi\ml [$H]serine (0.37-1.1 TBq\mmol, Amersham, Les Ulis, France) and effectors as indicated in the legends to the Figures. After incubation for 0-2 h the cells were rapidly sedimented in an Eppendorf centrifuge, the supernatants discarded and the cell phospholipids extracted with chloroform\ methanol by the method of Bligh and Dyer [13] . The lipid extracts were analysed by TLC in a solvent system composed of chloroform\methanol\acetic acid\water (75 : 45 : 12 : 3). Authentic phospholipid standards (Sigma) were run in parallel and detected with iodide vapours. Radioactivity in lipid spots was determined by using an automatic linear radiochromatography analyser (Berthold).
Measurements of CD69 and CD25
Cells (10'\ml) were incubated for 24 h in RPMI 1640\5 % fetal Figure 1C) ; on the contrary, the second [Ca# + ] i increase after the addition of 1 mM Ca# + in the medium was greatly dependent on the presence
Figure 2 Changes in [Ca 2 + ] i induced in Jurkat cells by thapsigargin (A) or CD3 monoclonal antibody (B)
The fluorescence of Indo-1 was measured in cells treated either with thapsigargin or CD3 alone ( ), in cells treated with 500 nM La 3 + added to the cell suspension at time 0 just before CD3 or thapsigargin () and in cells treated with either CD3 or thapsigargin at time 0 and then with 500 nM La Figure 1D ). [Ca# + ] i elevation was inhibited by La$ + when the cells were preincubated for 5 min before the CD3 treatment and also when La$ + was applied 3 min after CD3 mAb ( Figure 2B ). Similar results were obtained with cells treated with the endoplasmic reticulum Ca# + -ATPase blocker, thapsigargin (Figure 2A ). In previous papers we have shown that emptying intracellular stores of Jurkat cells inhibited the base-exchange enzyme system responsible for phosphatidylserine (PtdSer) synthesis [14, 15] . Measuring PtdSer synthesis was thus used as a tool to verify the status of intracellular Ca# + stores [16, 17] . PtdSer synthesis was inhibited both by CD3 mAb and thapsigargin and this process was not influenced by La$ + even at high concentrations (results not shown).
La 3 + does not act by penetrating Jurkat cells
It is accepted that La$ + does not penetrate cells even at very high concentrations. To verify this point, cells were first treated with 1 µM La$ + , followed immediately by CD3 mAb. Under these conditions, only a peak of Ca# + due to the release of Ca# + from intracellular stores was seen (Figure 3) . Then, at 4 min, 10 µM EGTA was added to the cell suspension. At this concentration, EGTA was unable to chelate a significant amount of Ca# + that was present at 1 mM but was quite able to chelate 1 µM La$ + owing to its very high affinity for that ion. Under these experimental conditions, the effect of La$ + was fully reversed by EGTA and the Ca# + entry recovered its previous ability. Identical results were observed with cells activated either with CD3 mAb or thapsigargin ( Figures 3A and 3B ).
La 3 + blocks Mn 2 + entry
Mn# + can be used as a Ca# + surrogate to estimate Ca# + influx through the plasma membrane [18] [19] [20] . Figure 4 shows that Mn# + entry into Jurkat cells as measured by the quenching of Indo-1 fluorescence at 430 nm is inhibited by La$ + . Similar results were obtained whether the cells were activated with CD3 mAb or thapsigargin.
La 3 + inhibits CD69 and CD25 expression
It is well known that the membrane expression of CD69 and CD25 reflects the state of activation of T lymphocytes. To see whether blocking the Ca# + channel modifies T-cell activation, we measured the expression of both CD69 and CD25 on cells activated for 24 h in the absence or presence of 1 µM La$ + . Figure 5 shows that La$ + blocks the membrane expression of these two activation markers, indicating that Ca# + influx is necessary to T-cell activation. SK&F 96365, a known inhibitor of Ca# + entry [21] , had a similar, although lower, effect at 3 µM ( Figure 5 ). That concentration was enough to abrogate the CD3-and thapsigargin-induced plateau of [Ca# + ] i increase by 90 %. Higher concentrations could not be used owing to the toxicity of this compound (results not shown).
DISCUSSION
In the present study, the efficacy of Ca# + entry compared with release from intracellular stores at activating Ca# + influx by plugging the CRAC. From these conclusions it was of interest to see whether some T-cell activation steps could be blocked by La$ + . As shown in Figure 5 , La$ + impaired CD25 and CD69 expression at the cell surface, indicating that the CRAC that maintains a high [Ca# + ] i is necessary for the expression of these two activation markers. This effect of La$ + is very probably due to Ca# + entry blockade because : (1) it was observed in cells treated with thapsigargin, which bypasses the early signalling cascade triggered by TCR stimulation, and (2) a similar inhibition was obtained independently with the Ca# + channel blocker SK&F 96365. Conversely, it can be concluded that the first activation signals such as tyrosine kinase activation, phospholipase Cγ1 phosphorylation, phosphatidylinositol bisphosphate hydrolysis and IP $ -induced Ca# + release from intracellular stores are not sufficient to induce CD25 and CD69 expression.
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